BIOLIFE SOLUTIONS INC (BLFS)
US09062W2044 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 35.41M | 19.40M | 69.90M | 90.40M | 6.40M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 18.66M | 33.90M | 23.20M | 8.00M | 5.30M | |||
| Inventories | 43.46M | 34.90M | 28.30M | 11.60M | 11.00M | |||
| Other Current Assets | 23.08M | 50.20M | 4.70M | 4.70M | 1.30M | |||
| Total Current Assets | 120.60M | 138.50M | 126.10M | 114.70M | 24.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 40.33M | 48.30M | 46.60M | 24.50M | 10.50M | |||
| Investments And Advances | 5.07M | 5.10M | 4.40M | 5.90M | 2.50M | |||
| Goodwill | 224.74M | 224.70M | 224.70M | 58.40M | 33.60M | |||
| Intangibles | 21.15M | 32.10M | 152.10M | 31.00M | 22.00M | |||
| Other Non-Current Assets | 821.00K | 1.60M | 300.00K | 200.00K | 100.00K | |||
| Total Non-Current Assets | 292.11M | 311.70M | 428.20M | 120.10M | 68.70M | |||
| TOTAL ASSETS | 412.71M | 450.20M | 554.30M | 234.80M | 92.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 7.21M | 2.00M | 1.00M | 600.00K | N/A | |||
| Accrued Expenses | 19.51M | 16.20M | 11.40M | 4.90M | 4.20M | |||
| Accounts Payable | 6.94M | 15.40M | 14.90M | 3.70M | 3.10M | |||
| Other Current Liabilities | 8.52M | 11.00M | 15.30M | 6.30M | 400.00K | |||
| Total Current Liabilities | 42.18M | 44.60M | 42.70M | 15.60M | 7.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 19.48M | 23.90M | 6.60M | 700.00K | 0.00 | |||
| Deferred Taxes/Income | 188.00K | 300.00K | 5.50M | N/A | N/A | |||
| Other Non-Current Liabilities | 13.21M | 17.30M | 21.40M | 13.30M | 41.70M | |||
| Total Non-Current Liabilities | 32.87M | 41.40M | 33.50M | 14.00M | 41.70M | |||
| TOTAL LIABILITIES | 75.05M | 86.00M | 76.20M | 29.60M | 49.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -313.34M | -246.90M | -107.10M | -97.40M | -100.10M | |||
| Additional Paid In Capital | 651.30M | 611.70M | 585.40M | 302.60M | 143.50M | |||
| Minority Interest | N/A | N/A | N/A | N/A | N/A | |||
| Common Shares | 45.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -345.00K | -700.00K | -300.00K | N/A | N/A | |||
| Shares Outstanding | 45.17M | 42.80M | 41.80M | 33.00M | 20.80M | |||
| Tangible Book Value per Share | 2.03 | 2.51 | 2.42 | 3.51 | -0.58 | |||
| Total Shareholders' Equity | 337.66M | 364.20M | 478.00M | 205.20M | 43.50M | |||
| TOTAL LIABILITIES AND EQUITY | 412.71M | 450.20M | 554.30M | 234.80M | 92.80M | |||
| Statistics | ||||||||
| Debt/Equity | 0.06 | 0.07 | 0.01 | 0.00 | N/A | |||
| Current Ratio | 2.86 | 3.11 | 2.95 | 7.35 | 3.13 | |||
| Return On Assets (ROA) | -16.10% | -31.05% | -1.61% | 0.77% | -1.83% | |||
| Return On Equity (ROE) | -19.67% | -38.39% | -1.86% | 0.88% | -3.91% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | 0.65% | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | 0.70% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | N/A | N/A | 2.39% | |||
All data in USD